13/05/2015 NIHR Research Training Opportunities NIHR Trainees Coordinating Centre Dr Doreen Tembo.
Encouraging adaptive designs in NiHR funded clinical trials
description
Transcript of Encouraging adaptive designs in NiHR funded clinical trials
![Page 1: Encouraging adaptive designs in NiHR funded clinical trials](https://reader035.fdocuments.us/reader035/viewer/2022062520/568159df550346895dc729e0/html5/thumbnails/1.jpg)
Encouraging adaptive designs in NiHR funded clinical trials
Professor Sallie Lamb
Chair, CET Board
![Page 2: Encouraging adaptive designs in NiHR funded clinical trials](https://reader035.fdocuments.us/reader035/viewer/2022062520/568159df550346895dc729e0/html5/thumbnails/2.jpg)
Welcome and Housekeeping
• Bathroom facilities
• Break-out areas
• Coffee and lunch
• Fire alarm and drill
• Travel expenses
• Queries
![Page 3: Encouraging adaptive designs in NiHR funded clinical trials](https://reader035.fdocuments.us/reader035/viewer/2022062520/568159df550346895dc729e0/html5/thumbnails/3.jpg)
Adaptive designs
• Most discussion has arisen from drug development and approval trials
• Most guidance is provided within this context
• Most methodological development has also been within this context
• Fit for purpose for NiHR trials (HTA) ?
• When indicated ?
• How facilitated ?
![Page 4: Encouraging adaptive designs in NiHR funded clinical trials](https://reader035.fdocuments.us/reader035/viewer/2022062520/568159df550346895dc729e0/html5/thumbnails/4.jpg)
Adaptive designs
• Covers many different types of adaptation
• Futility and early stopping
• Treatment selection
• Dose response
• Sub-group refinement
• Interim sample size re-estimation
![Page 5: Encouraging adaptive designs in NiHR funded clinical trials](https://reader035.fdocuments.us/reader035/viewer/2022062520/568159df550346895dc729e0/html5/thumbnails/5.jpg)
Adaptive designs
• Some applications not well understood
• Many myths – around speed, cost and method
• Widely accepted that operational issues are as important as statistical issues
![Page 6: Encouraging adaptive designs in NiHR funded clinical trials](https://reader035.fdocuments.us/reader035/viewer/2022062520/568159df550346895dc729e0/html5/thumbnails/6.jpg)
NiHR funded research is different
• NiHR HTA programme – largest funder of academic clinical trials in the UK – pragmatic, phase III
• Commissioned and responsive mode
• NiHR EME programme – phase II/mechanistic
• NiHR programme grants
• NiHR fellowship applications
![Page 7: Encouraging adaptive designs in NiHR funded clinical trials](https://reader035.fdocuments.us/reader035/viewer/2022062520/568159df550346895dc729e0/html5/thumbnails/7.jpg)
Trial phases
![Page 8: Encouraging adaptive designs in NiHR funded clinical trials](https://reader035.fdocuments.us/reader035/viewer/2022062520/568159df550346895dc729e0/html5/thumbnails/8.jpg)
Pharmaceutical Industry HTA
To demonstrate superiority, or equivalence/n-i with better safety profile
To estimate superiority, equivalence, n-i with better safety profile
Risk of accepting null hypothesis to be minimised or eliminated prior to Phase III
Usually no risk to accepting null hypothesis - value of information remains high and investment worthwhile*
Drug trials for regulatory approval Few trials to support regulatory approval
Main driver of design – companies/regulator
Main driver of design – academics/funder
Outcomes - disease specific as primary
Various layers of outcome – disease specific, generic HQoL, cost
Comparators – placebo and/or active control
Comparators – usual care/ best current practice
Maximise effect prior to Phase III (a) Evaluate effect in everyday settings
![Page 9: Encouraging adaptive designs in NiHR funded clinical trials](https://reader035.fdocuments.us/reader035/viewer/2022062520/568159df550346895dc729e0/html5/thumbnails/9.jpg)
O P E R A
OLDER PEOPLE’S EXERCISE IN RESIDENTIAL ACCOMMODATION
![Page 10: Encouraging adaptive designs in NiHR funded clinical trials](https://reader035.fdocuments.us/reader035/viewer/2022062520/568159df550346895dc729e0/html5/thumbnails/10.jpg)
So what is today about
• Identify the issues• Methodological• Logistical – recruitment, ethics• Logistical - funding arrangements*• Talks – stats, trialist, and economics• Discussion – stick-its, group work• Workshops• Dissemination
![Page 11: Encouraging adaptive designs in NiHR funded clinical trials](https://reader035.fdocuments.us/reader035/viewer/2022062520/568159df550346895dc729e0/html5/thumbnails/11.jpg)
Workshops
• What are the (applied) methodological questions that need to be addressed?
• What are the practical/organisational implications of using adaptive designs?
• What guide can we give for when adaptive designs should be considered?
• How should we encourage the greater use of adaptive designs in NiHR research?